Company / Inventory
GeneDx Holdings Corp. Inventory History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$14.0M
FY2025
5-year range
$8.8M / $33.5M
FY2021-FY2025
Trend
+31.0%
vs FY2024
Sector context
#109 of 118
Health Care
What the data says
Among 118 Health Care companies, GeneDx Holdings Corp. is in the bottom 8% for inventory. Improved from $9M to $14M over the past 2 years.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of -11.0%.
Improved from $9M to $14M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- -11.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 118This company $14.0M Sector average $1.4B
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.0%, indicating a declining trend.
- In FY2025, inventory increased 31.0% year-over-year.
- Ranks #109 out of 118 companies in the Health Care sector.
- Peak inventory was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.0M | +31.0% |
| FY2024 | $10.7M | +21.3% |
| FY2023 | $8.8M | -35.8% |
| FY2022 | $13.7M | -59.2% |
| FY2021 | $33.5M | +34.0% |
| FY2020 | $25.0M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026